OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
OrthoPediatrics (Nasdaq: KIDS) has announced its partnership with the Crossroads Pediatric Device Consortium (CPDC), a multi-institutional initiative focused on accelerating pediatric medical device development. The consortium includes Purdue University's Weldon School of Biomedical Engineering, the Indiana University School of Medicine's Department of Pediatrics, and Cook Medical.
This collaboration aims to strengthen the consortium's capabilities in developing and commercializing pediatric medical devices, particularly in orthopedics. The partnership leverages OrthoPediatrics' specialized expertise in pediatric orthopedics to enhance the consortium's innovative potential.
The CPDC's distinctive model integrates major medical device companies to streamline product development, regulatory navigation, and commercialization processes, ensuring efficient transition of pediatric medical innovations from concept to market.
OrthoPediatrics (Nasdaq: KIDS) ha annunciato la sua partnership con il Crossroads Pediatric Device Consortium (CPDC), un'iniziativa multi-istituzionale focalizzata sull'accelerazione dello sviluppo di dispositivi medici pediatrici. Il consorzio include la Weldon School of Biomedical Engineering della Purdue University, il Dipartimento di Pediatria della Indiana University School of Medicine e Cook Medical.
Questa collaborazione mira a rafforzare le capacità del consorzio nello sviluppo e nella commercializzazione di dispositivi medici pediatrici, in particolare in ortopedia. La partnership sfrutta l'expertise specializzata di OrthoPediatrics in ortopedia pediatrica per migliorare il potenziale innovativo del consorzio.
Il modello distintivo del CPDC integra importanti aziende di dispositivi medici per semplificare lo sviluppo del prodotto, la navigazione normativa e i processi di commercializzazione, garantendo una transizione efficiente delle innovazioni mediche pediatriche dal concetto al mercato.
OrthoPediatrics (Nasdaq: KIDS) ha anunciado su asociación con el Crossroads Pediatric Device Consortium (CPDC), una iniciativa multiinstitucional centrada en acelerar el desarrollo de dispositivos médicos pediátricos. El consorcio incluye la Weldon School of Biomedical Engineering de la Universidad de Purdue, el Departamento de Pediatría de la Escuela de Medicina de la Universidad de Indiana y Cook Medical.
Esta colaboración tiene como objetivo fortalecer las capacidades del consorcio en el desarrollo y comercialización de dispositivos médicos pediátricos, especialmente en ortopedia. La asociación aprovecha la experiencia especializada de OrthoPediatrics en ortopedia pediátrica para aumentar el potencial innovador del consorcio.
El modelo distintivo del CPDC integra a importantes empresas de dispositivos médicos para agilizar el desarrollo de productos, la navegación regulatoria y los procesos de comercialización, asegurando una transición eficiente de las innovaciones médicas pediátricas desde el concepto hasta el mercado.
OrthoPediatrics (Nasdaq: KIDS)는 Crossroads Pediatric Device Consortium (CPDC)와의 파트너십을 발표했습니다. 이 다기관 이니셔티브는 소아 의료 기기 개발을 가속화하는 데 중점을 두고 있습니다. 이 컨소시엄에는 퍼듀 대학교 생물 의공학 웰돈 스쿨, 인디애나 대학교 의과대학 소아과, 그리고 쿡 메디컬이 포함됩니다.
이번 협력은 특히 정형외과 분야에서 소아 의료 기기의 개발 및 상용화에 있어 컨소시엄의 역량을 강화하는 것을 목표로 하고 있습니다. 이 파트너십은 OrthoPediatrics의 소아 정형외과에 대한 전문 지식을 활용하여 컨소시엄의 혁신 잠재력을 향상시킵니다.
CPDC의 독특한 모델은 주요 의료 기기 회사들을 통합하여 제품 개발, 규제 탐색 및 상용화 프로세스를 간소화하여 소아 의료 혁신이 개념에서 시장으로 효율적으로 전환될 수 있도록 보장합니다.
OrthoPediatrics (Nasdaq: KIDS) a annoncé son partenariat avec le Crossroads Pediatric Device Consortium (CPDC), une initiative multi-institutionnelle axée sur l'accélération du développement de dispositifs médicaux pédiatriques. Le consortium comprend la Weldon School of Biomedical Engineering de l'Université de Purdue, le Département de Pédiatrie de l'École de Médecine de l'Université de l'Indiana et Cook Medical.
Cette collaboration vise à renforcer les capacités du consortium dans le développement et la commercialisation de dispositifs médicaux pédiatriques, en particulier en orthopédie. Le partenariat tire parti de l'expertise spécialisée d'OrthoPediatrics en orthopédie pédiatrique pour améliorer le potentiel d'innovation du consortium.
Le modèle distinctif du CPDC intègre de grandes entreprises de dispositifs médicaux pour rationaliser le développement de produits, la navigation réglementaire et les processus de commercialisation, garantissant ainsi une transition efficace des innovations médicales pédiatriques du concept au marché.
OrthoPediatrics (Nasdaq: KIDS) hat seine Partnerschaft mit dem Crossroads Pediatric Device Consortium (CPDC) bekannt gegeben, einer multi-institutionellen Initiative, die sich auf die Beschleunigung der Entwicklung pädiatrischer medizinischer Geräte konzentriert. Das Konsortium umfasst die Weldon School of Biomedical Engineering der Purdue University, die Pädiatrische Abteilung der Indiana University School of Medicine und Cook Medical.
Diese Zusammenarbeit zielt darauf ab, die Fähigkeiten des Konsortiums in der Entwicklung und Vermarktung pädiatrischer medizinischer Geräte, insbesondere in der Orthopädie, zu stärken. Die Partnerschaft nutzt das spezialisierte Fachwissen von OrthoPediatrics in der pädiatrischen Orthopädie, um das innovative Potenzial des Konsortiums zu erhöhen.
Das einzigartige Modell des CPDC integriert große Unternehmen im Bereich medizinischer Geräte, um die Produktentwicklung, die regulatorische Navigation und die Vermarktungsprozesse zu optimieren, und gewährleistet einen effizienten Übergang pädiatrischer medizinischer Innovationen vom Konzept zum Markt.
- Strategic partnership enhances product development capabilities
- Access to multi-institutional expertise and resources
- Streamlined regulatory and commercialization processes
- None.
WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company’s cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.
The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding members include Purdue University’s Weldon School of Biomedical Engineering, the Indiana University School of Medicine’s Department of Pediatrics, and Cook Medical, a leader in medical device manufacturing. OrthoPediatrics' addition to the consortium brings specialized expertise in pediatric orthopedics, further strengthening the consortium's capabilities to develop and commercialize pediatric medical devices.
“We are proud to join the Crossroads Pediatric Device Consortium, as it aligns with our cause of advancing healthcare for KIDS all over the world,” said David Bailey, President & CEO of OrthoPediatrics. “By collaborating with CPDC's network of experts, we aim to drive innovation in pediatric medical technology and ensure children have access to the specialized treatments they need.”
Matthew Waninger, Managing Director of Crossroads Pediatric Device Consortium, welcomed the partnership, stating: “OrthoPediatrics has been a leader in pediatric orthopedics for years, and we are thrilled to have them as part of our consortium. Their expertise and dedication to pediatric innovation will be invaluable as we work to accelerate the development and accessibility of breakthrough medical devices for children.”
With OrthoPediatrics joining, the Crossroads Pediatric Device Consortium strengthens its industry partnerships through a distinctive model that directly integrates major medical device companies. By integrating industry leaders into its network, the consortium streamlines product development, regulatory navigation, and commercialization, ensuring pediatric medical innovations move efficiently from concept to market.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.
About Crossroads Pediatric Device Consortium (CPDC)
The Crossroads Pediatric Device Consortium is a collaborative initiative between Purdue University’s Weldon School of Biomedical Engineering, the Indiana University School of Medicine’s Department of Pediatrics, and Cook Medical. Crossroads Pediatric Device Consortium aims to bridge the gap between research, clinical needs, and industry by fostering partnerships that accelerate the development, approval, and commercialization of pediatric medical devices.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
What is the purpose of OrthoPediatrics (KIDS) joining the Crossroads Pediatric Device Consortium?
Who are the founding members of the Crossroads Pediatric Device Consortium partnering with KIDS?
How will the CPDC partnership affect OrthoPediatrics' (KIDS) product development process?
What is the strategic significance of the March 2025 CPDC collaboration for KIDS shareholders?
